Felix vs Injective

Compare Felix and Injective on TVL, fees, revenue and activity to understand how these projects stack up.

$57.23M
Felix is an on-chain financial services platform providing unified access to decentralized trading and lending markets. It combines spot equities, perpetual futures, and lending products within a single interface, enabling users to trade tokenized assets, access leverage, and earn yield efficiently. Its CDP-based feUSD market allows users to deposit collateral and mint a stable asset for leveraged strategies, while vanilla lending pools offer variable-rate borrowing and lending with full asset exposure. Designed for global, 24/7 access, Felix emphasizes deep liquidity, low costs, and strong risk management through audited smart contracts and continuous security monitoring.
View Full Page
Injective Perps is the perpetual futures market of Injective, a layer 1 blockchain optimized for finance. Trading runs on Injective's native onchain order book module, which offers fully onchain matching and settlement, front-running resistance through frequent batch auctions and very low fees. Markets cover major crypto assets as well as real-world assets such as equities, commodities and forex, and the shared liquidity layer is used by multiple trading front-ends built on Injective. Part of the fees feeds the INJ burn auction.
View Full Page

Key Metrics Comparison

Felix
TVL
$57.23M
24h Volume
N/A
24h Fees
$3.1K
24h Revenue
$196
30d Fees
$117.5K
30d Revenue
$7.8K
7d TVL Change
-12.19%
Dominance
0.06%
Injective
TVL
N/A
24h Volume
$4.43M
24h Fees
N/A
24h Revenue
N/A
30d Fees
N/A
30d Revenue
N/A
7d TVL Change
N/A
Dominance
0.00%

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

TVL Share

Share of combined TVL

TVL Share
Felix
1.0%
Injective
1.0%

Volume Share

Share of combined 24h volume

Volume Share
Felix
1.0%
Injective
1.0%

Fees Share

Share of combined 24h fees

Fees Share
Felix
1.0%
Injective
1.0%

Revenue Share

Share of combined 24h revenue

Revenue Share
Felix
1.0%
Injective
1.0%

7d TVL Performance

TVL change over last 7 days

7d TVL Performance
Felix
-12.19%
Injective
N/A

Dominance

Market dominance by TVL

Dominance
Felix
0.1%
Injective
0.0%